Senatec HC Interactions
There are 94 drugs known to interact with Senatec HC (hydrocortisone / lidocaine topical), along with 10 disease interactions. Of the total drug interactions, 2 are major, and 92 are moderate.
- View all 94 medications that may interact with Senatec HC
- View Senatec HC disease interactions (10)
Most frequently checked interactions
View interaction reports for Senatec HC (hydrocortisone / lidocaine topical) and the medicines listed below.
- acyclovir
- albuterol
- Aleve (naproxen)
- Antibacterial Clean & Smooth (triclosan topical)
- aspirin
- atorvastatin
- Bengay Ultra Strength Cream (camphor / menthol / methyl salicylate topical)
- Biotene Mouthwash (saliva substitutes topical)
- citric acid/sodium citrate
- clonazepam
- Colace (docusate)
- ControlRx Toothpaste (fluoride topical)
- dexamethasone
- DOK (docusate)
- Dulcolax Laxative (bisacodyl)
- Dulcolax Stool Softener (docusate)
- Dulera (formoterol / mometasone)
- Eliquis (apixaban)
- gabapentin
- glucosamine
- High Potency B Complex with B12 and C (multivitamin)
- hydrochlorothiazide
- Laxative Natural (psyllium)
- lenalidomide
- lisinopril
- melatonin
- meloxicam
- Metamucil Orange Smooth Texture Sugar Free (psyllium)
- MiraLAX (polyethylene glycol 3350)
- Narcan (naloxone)
Senatec HC disease interactions
There are 10 disease interactions with Senatec HC (hydrocortisone / lidocaine topical) which include:
- teething pain
- cardiovascular dysfunction
- hepatic dysfunction
- renal dysfunction
- seizures
- diabetes
- diaper rash
- hyperadrenocorticism
- infections
- ocular toxicities
More about Senatec HC (hydrocortisone / lidocaine topical)
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: topical anesthetics
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.